Metropolitan Life Insurance CO Rapt Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$6.87 - $26.45 $2,198 - $8,464	-320 Reduced 16.83%	1,581 $14,000
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $5,114 - $7,718	313 Added 19.71%	1,901 $31,000
Q2 2022 Mar 30, 2023	BUY	$10.26 - $23.59 $3,396 - $7,808	331 Added 26.33%	1,588 $28,000
Q2 2022 Aug 11, 2022	BUY	$10.26 - $23.59 $3,396 - $7,808	331 Added 26.33%	1,588 $29,000
Q1 2022 Jun 20, 2023	SELL	$17.02 - $40.22 $5,633 - $13,312	-331 Reduced 20.84%	1,257 $27,000
Q1 2022 Mar 30, 2023	SELL	$17.02 - $40.22 $69,271 - $163,695	-4,070 Reduced 76.4%	1,257 $27,000
Q1 2022 May 12, 2022	SELL	$17.02 - $40.22 $69,271 - $163,695	-4,070 Reduced 76.4%	1,257 $28,000
Q4 2021 Jun 21, 2023	BUY	$29.5 - $39.5 $110,300 - $147,690	3,739 Added 235.45%	5,327 $195,000
Q3 2021 Jun 21, 2023	BUY	$29.86 - $39.47 $111,646 - $147,578	3,739 Added 235.45%	5,327 $165,000
Q2 2021 Jun 21, 2023	BUY	$17.99 - $40.02 $67,264 - $149,634	3,739 Added 235.45%	5,327 $169,000
Q2 2021 Mar 30, 2023	BUY	$17.99 - $40.02 $29,485 - $65,592	1,639 Added 44.44%	5,327 $169,000
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $95,832 - $213,186	5,327 New	5,327 $169,000
Q4 2020 Feb 16, 2021	SELL	$15.89 - $40.87 $58,602 - $150,728	-3,688 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$21.6 - $37.5 $45,360 - $78,750	2,100 Added 132.24%	3,688 $118,000
Q2 2020 Jun 26, 2023	BUY	$14.16 - $32.85 $29,736 - $68,985	2,100 Added 132.24%	3,688 $107,000
Q2 2020 Mar 30, 2023	BUY	$14.16 - $32.85 $29,736 - $68,985	2,100 Added 132.24%	3,688 $107,000
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $52,222 - $121,150	3,688 New	3,688 $107,000

Others Institutions Holding RAPT

# of Institutions

105

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

Vanguard Group Inc Valley Forge, PA

3.16M
Shares

$3.79 Million
0.0% of portfolio
Column Group LLC San Francisco, CA

2.68M
Shares

$3.22 Million
7.75% of portfolio
Black Rock Inc. New York, NY

2.44M
Shares

$2.93 Million
0.0% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

1.73M
Shares

$2.07 Million
0.42% of portfolio
Ponoi Management, LLC San Francisco, CA

1.6M
Shares

$1.92 Million
52.54% of portfolio

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $35.6M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account